Patent · US Active

Treatment and prevention of stroke and other neurological disorders

US10220008B2 · kind B2 · utility

0Cited by
15References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 14, 2014
Grant dateMar 5, 2019
Priority date
Expiry dateNov 21, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/5058
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Using high-throughput screening, in an oxygen-glucose deprivation (OGD) model, isoxsuprine hydrochloride was identified as a potent neuroprotective compound. In an animal middle artery occlusion (MCAO) model of transient focal ischemia, isoxsuprine significantly reduced infarct volume compared to vehicle. The invention, therefore, provides methods of treatment and pharmaceutical compositions that are useful in the treatment and prevention of a wide-variety of ischemia-related injuries, including stroke.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.